| Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients (NCT05355766) | Hangzhou Zede Pharma-Tech Co., Ltd. | 2022-06-13 |
| Inhibitory Effect of a Polyphenol Supplement on Dietary Iron Absorption in Adults with Thalassemia (NCT05326503) | Swiss Federal Institute of Technology | 2022-06-01 |
| MRI QSM Imaging for Iron Overload (NCT04631718) | University of Wisconsin, Madison | 2022-01-18 |
| Safety of SP-420 in the Treatment of Transfusional Iron Overload (NCT04741542) | The University of Texas Health Science Center at San Antonio | 2021-03-09 |
| Risk Factors and Measures to Prevent Liver and Pancreas Complications in Pediatric Patients After HSCT (NCT04423237) | University of Pisa | 2020-09-30 |
| Long-term Clinical Study of CN128 in Thalassemia Patients (NCT04614779) | Hangzhou Zede Pharma-Tech Co., Ltd. | 2020-09-30 |
| SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare Anemias (NCT03801889) | Abfero Pharmaceuticals, Inc | 2020-08-01 |
| MRI T2* Mapping of Myocardium, Liver, Pancreas and Pituitary Gland (NCT04835285) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2020-01-21 |
| Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemia (NCT04292314) | Beni-Suef University | 2019-11-01 |
| Inhibiting Dietary Iron Absorption in Subjects With Hereditary Hemochromatosis by a Natural Polyphenol Supplement (NCT03990181) | Swiss Federal Institute of Technology | 2019-09-20 |
| Validation of a Point-of-care Device Measuring Ferritin With Capillary Blood (NCT03800446) | McMaster University | 2019-09-01 |
| Ethnic Differences in Iron Absorption (FeGenes) (NCT04198545) | Cornell University | 2019-08-01 |
| The Iron Content of Ferritin in Serum and Urine of Children With High Serum Ferritin Levels (NCT03777904) | University of Utah | 2019-02-21 |
| Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children (NCT03591575) | Chiesi Canada Corp | 2018-11-09 |
| Safety Study of Crushed Deferasirox Film Coated Tablets in Pediatric Patients With Transfusional Hemosiderosis (NCT03372083) | Novartis Pharmaceuticals | 2018-01-16 |
| Iron Supplementation and Side Effects (NCT04018300) | Iowa State University | 2018-01-08 |
| Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group (NCT03141398) | Hamad Medical Corporation | 2017-08-01 |
| Endocrine Function During Deferasirox Therapy (NCT04515680) | University of Campania Luigi Vanvitelli | 2016-11-02 |
| Study of MRI Monitoring in Patients With Aplastic Anemia and Low or Int-1 Risk of MDS Complicated With Iron Overload (NCT02833493) | Peking Union Medical College Hospital | 2016-09-01 |
| Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content (NCT02025543) | University of Wisconsin, Madison | 2015-08-12 |
| Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients (NCT02474420) | Kevin H.M. Kuo, MD, MSc, FRCPC | 2015-06-01 |
| Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias (NCT02443545) | ApoPharma | 2015-05-21 |
| Non-invasive Quantification of Liver Iron With MRI (NCT02425956) | GE Healthcare | 2015-04-01 |
| Treatment of Iron Overload Requiring Chelation Therapy (NCT01927913) | Shire | 2014-11-20 |
| Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemia (NCT02274233) | Sideris Pharmaceuticals | 2014-10-01 |
| Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias (NCT02041299) | ApoPharma | 2014-04-17 |
| Iron Homoeostasis in Inflammation (NCT02155114) | University Hospital, Basel, Switzerland | 2014-04-01 |
| Evaluation of Myocardial Iron Deposition in Patients of Heart Failure Using T2* MR Imaging (NCT02527330) | Chang Gung Memorial Hospital | 2014-01-01 |
| Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) Patients (NCT02164253) | University Hospital, Lille | 2013-09-01 |
| "Iron Overload and Endocrinological Diseases" (NCT06137079) | Azienda Ospedaliero-Universitaria di Modena | 2013-06-20 |
| Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major (NCT01395199) | University of Campinas, Brazil | 2012-08-01 |
| Massive Iron Deposit Assessment (NCT01572922) | St. Jude Children's Research Hospital | 2012-06-11 |
| Non-invasive Quantification of Liver Iron With MRI (NCT01516853) | University of Wisconsin, Madison | 2012-01-01 |
| Iron Metabolism in Small Pre Term Newborns (NCT01443195) | HaEmek Medical Center, Israel | 2011-10-01 |
| Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia (NCT01546415) | Novartis Pharmaceuticals | 2011-10-01 |
| Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis (NCT01342705) | Assistance Publique - Hôpitaux de Paris | 2011-05-01 |
| Renal Function Among Thalassemia Patients Treated by a Oral Chelator Deferasirox (NCT01905774) | HaEmek Medical Center, Israel | 2011-03-01 |
| Oxidative Stress and Apoptosis of Energy Metabolism by Deferiprone From the Circulating Lymphocytes (NCT02880033) | University Hospital, Lille | 2011-02-01 |
| Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients (NCT01572818) | Rennes University Hospital | 2010-10-01 |
| Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload (NCT01159067) | City of Hope Medical Center | 2010-07-01 |
| Fetal Parenchymatic Evaluation (Liver, Spleen) Using T2* Sequences (NCT01121094) | Sheba Medical Center | 2010-06-01 |
| Assessment of Iron Deposition in Major Organs of Hemodialysis Patients (NCT01169961) | Wolfson Medical Center | 2010-02-01 |
| Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload (NCT01369719) | Hormozgan University of Medical Sciences | 2010-02-01 |
| Phlebotomy and Lifestyle and Diet Advices vs Lifestyle and Diet Advices Only in Patients With Dysmetabolic Liversiderosis (NCT01045525) | Rennes University Hospital | 2010-01-01 |
| Iron Overload in Pediatric Oncology Patients (NCT01034072) | Northwell Health | 2009-12-01 |
| Therapeutic Effects of Silymarin in Patients With B-thalassemia Major (NCT00999349) | Isfahan University of Medical Sciences | 2009-03-01 |
| Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload (NCT01335035) | Novartis Pharmaceuticals | 2008-12-01 |
| Changes in Pituitary Iron and Volume With Deferasirox (NCT01376622) | Children's Hospital Los Angeles | 2008-11-01 |
| Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA) (NCT00907283) | Ente Ospedaliero Ospedali Galliera | 2008-11-01 |
| Effects of Taking Prenatal Vitamin-mineral Supplements During Lactation on Iron Status and Markers of Oxidation (NCT01047098) | University of California, Davis | 2008-10-01 |
| Oral Nifedipine to Treat Iron Overload (NCT00712738) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2008-06-20 |
| Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload (NCT00654589) | Novartis Pharmaceuticals | 2008-02-01 |
| MRI Evaluation of Iron Overload in the Heart, Liver and Pancreas in Patients Receiving Multiple Blood Transfusions. (NCT00629291) | Sheba Medical Center | 2008-01-01 |
| Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia (NCT00512226) | HaEmek Medical Center, Israel | 2007-09-01 |
| Combined Chelation Therapy in Patients With Transfusion Dependent Thalassemia and Iron Overload (NCT00901199) | Elliott Vichinsky | 2007-09-01 |
| Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients (NCT00529152) | ApoPharma | 2007-08-01 |
| Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant (NCT00602446) | Masonic Cancer Center, University of Minnesota | 2007-08-01 |
| Safety and Efficacy of Iron Reduction by Phlebotomy (NCT00689182) | Andrea Kew | 2007-05-01 |
| Iron Overload in Stem Cell Transplant Recipients (NCT00806715) | Boston Children's Hospital | 2007-02-01 |
| Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance Imaging (NCT00401336) | Rennes University Hospital | 2006-11-01 |
| Study of the Effects of Muscular Activity on Iron Metabolism (NCT00378469) | Rennes University Hospital | 2006-09-01 |
| Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis (NCT00395629) | Novartis Pharmaceuticals | 2006-08-01 |
| Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease (NCT00293098) | Children's Hospital of Philadelphia | 2006-03-01 |
| Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment (NCT00447694) | Novartis | 2006-02-01 |
| Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients (NCT00117507) | Novartis Pharmaceuticals | 2005-09-01 |
| Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients (NCT00110266) | Novartis Pharmaceuticals | 2005-07-25 |
| Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration) (NCT00171301) | Novartis Pharmaceuticals | 2005-06-01 |
| Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients (NCT00110617) | Novartis Pharmaceuticals | 2005-05-01 |
| Cytochrome P450 2E1 and Iron Overload (NCT00138684) | Rennes University Hospital | 2003-09-01 |
| Retrospective Evaluation of Adult and Pediatric Transfusion-dependent Patients Treated With Deferasirox Therapy (NCT01874405) | University of Campania Luigi Vanvitelli | 2003-03-01 |
| Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major (NCT00800761) | Ospedale Microcitemico | 2001-12-01 |
| Hemochromatosis and Iron Overload Screening Study (HEIRS) (NCT00005541) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-01-01 |
| Combination Iron Chelation Therapy (NCT00004982) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1998-12-01 |
| Iron Overload in African Americans (NCT00001455) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1995-06-01 |
| Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone (NCT00000588) | Case Western Reserve University | 1989-06-05 |
| Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis (NCT00000595) | National Heart, Lung, and Blood Institute (NHLBI) | 1978-01-01 |